Immunocytochemical Localization of the 1,25-Dihydroxyvitamin D3Receptor in Target Cells*
- 1 April 1988
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 122 (4), 1224-1230
- https://doi.org/10.1210/endo-122-4-1224
Abstract
We have used a monoclonal antibody (9A7) against the purified avian 1,25-dihydroxyvitamin D3 receptor to develop an immunocytochemical technique for visualization of the protein in fixed tissues and cultured cells. In Bouin''s-fixed, chick intestine, 1,25-dihydroxyvitamin D3 receptor-like immunoreactivity was localized mainly in nuclei of epithelial cells and was more abundant in the crypt than in the villar cells. Receptor staining was low or undetectable in liver hepatocytes but was present in nuclei of cells lining the hepatic sinusoids. In rat brain, receptor-like immunoreactivity was abundant and widely distributed, but did not always coincide with the presence of vitamin D-dependent calcium-binding protein; 1,25-dihydroxyvitamin D3 receptor was absent from cerebellar Purkinje cells that contained abundant calcium-binding protein. In disaggregated rat bone cells, receptor immunoreactivity was present in mononuclear cells including osteoclasts. Two separate clones of osteoblast-like, rat osteosarcoma cells, shown in previous studies to be either receptor positive (17/2.8) or negative (24.1), demonstrated nuclear immunoreactivity in exact concordance with receptor levels as determined by ligand binding. The phenomenon of hormone-induced up-regulation of receptor was visualized in receptor-positive 3T6 fibroblasts by demonstration of markedly enhanced nuclear reactivity in cells treated with 10-7 M 1,25-dihydroxyvitamin D3 for 48 h. Our studies demonstrate the feasibility of the immunocytochemical approach to visualize the 1,25-dihydroxyvitamin D3 receptor in target tissues and show that it is predominantly a nuclear protein in the relatively unoccupied and fully activated states. Moreover, the vitamin D-dependent calcium binding is not a universal marker for 1,25-dihydroxyvitamin D3 action. Rather, our observations suggest that the expression of the 1,25-dihydroxyvitamin D3 receptor may be connected with the state of cellular differentiation.This publication has 21 references indexed in Scilit:
- INFLUENCE OF 1,25-DIHYDROXYVITAMIN-D3 ON CULTURED OSTEOGENIC-SARCOMA CELLS - CORRELATION WITH THE 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR1984
- Intestinal vitamin D-induced calcium-binding protein: time-course of immunocytological localization following 1,25-dihydroxyvitamin D3.Journal of Histochemistry & Cytochemistry, 1983
- RAT VITAMIN-D-DEPENDENT CALCIUM-BINDING PROTEINS - SPECIFICITY OF MESSENGER-RNAS CODING FOR THE 7500-MR PROTEIN FROM DUODENUM AND THE 28000-MR PROTEIN FROM KIDNEY AND CEREBELLUM1983
- Vitamin D-Dependent Calcium-Binding Protein in Rat Brain: Biochemical and Immunocytochemical Characterization*Endocrinology, 1983
- Development of hybridomas secreting monoclonal antibodies to the chicken intestinal 1 alpha,25-dihydroxyvitamin D3 receptor.Proceedings of the National Academy of Sciences, 1982
- Brain Target Sites for 1,25-Dihydroxyvitamin D 3Science, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Studies on the Mode of Action of Calciferol. XIII. Development of a Radioimmunoassay for Vitamin DDependent Chick Intestinal Calcium-Binding Protein and Tissue Distribution*Endocrinology, 1979
- Scintillation Autoradiographic Localization of 1,25 Dihydroxyvitamin D3in Chick Intestine*Endocrinology, 1979
- Maintenance of parathyroid hormone response in clonal rat osteosarcoma linesExperimental Cell Research, 1978